GWPH - GW Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.56B
Enterprise Value 33.07B
Trailing P/E N/A
Forward P/E 1-146.81
PEG Ratio (5 yr expected) 1-0.67
Price/Sales (ttm)16.15
Price/Book (mrq)4.92
Enterprise Value/Revenue 313.92
Enterprise Value/EBITDA 6-20.25

Trading Information

Stock Price History

Beta (5Y Monthly) 2.13
52-Week Change 3-17.07%
S&P500 52-Week Change 325.78%
52 Week High 3196.00
52 Week Low 395.71
50-Day Moving Average 3107.48
200-Day Moving Average 3128.58

Share Statistics

Avg Vol (3 month) 3741.68k
Avg Vol (10 day) 3807.77k
Shares Outstanding 530.91M
Float 30.06M
% Held by Insiders 10.96%
% Held by Institutions 184.08%
Shares Short (Dec. 30, 2019) 45.72M
Short Ratio (Dec. 30, 2019) 48.93
Short % of Float (Dec. 30, 2019) 4N/A
Short % of Shares Outstanding (Dec. 30, 2019) 418.51%
Shares Short (prior month Nov. 28, 2019) 45.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin -17.42%
Operating Margin (ttm)-73.34%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)220.13M
Revenue Per Share (ttm)6.78
Quarterly Revenue Growth (yoy)3,659.10%
Gross Profit (ttm)-19.8M
EBITDA -151.33M
Net Income Avi to Common (ttm)-38.35M
Diluted EPS (ttm)-1.26
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)554.68M
Total Cash Per Share (mrq)17.94
Total Debt (mrq)37.25M
Total Debt/Equity (mrq)5.18
Current Ratio (mrq)7.33
Book Value Per Share (mrq)23.28

Cash Flow Statement

Operating Cash Flow (ttm)-225.05M
Levered Free Cash Flow (ttm)N/A